GLP-1 and specialty drug costs are a growing pressure point for employers. Specialty Care Accounts cap employer exposure and restore cost predictability—supporting GLP-1s, HRT, and specialty mental health while preserving employee access and choice.
See how a capped specialty care budget could lower your GLP-1 spend.
Traditional medical plans weren't built for today's specialty drug costs. Specialty Care Accounts give employers a capped, predictable way to fund high-cost care.
Employers covering GLP-1s today can significantly reduce spend by shifting from open-ended formulary coverage to a capped, employer-defined funding model.
A sustainable option for employers not yet offering GLP-1s who want budget predictability without committing to open-ended costs.
Funds can be used with eligible digital, retail, or in-person providers—including direct-to-consumer options—so employees keep access and choice.
The same structure can support additional high-cost specialty categories such as mental health, hormonal health (HRT), and out-of-pocket medical expenses.
Specialty drug demand is driving employer healthcare spend to its fastest pace in years. A capped model changes the math.
Figures are directional and based on Espresa's launch data and an illustrative employer scenario; actual results vary by population, utilization, and program design. Please confirm before publishing.
Traditional medical plans weren't designed for today's specialty drug costs—leaving employers with hard tradeoffs.
Adding high-cost categories like GLP-1s directly to the medical plan creates major cost pressure and renewal shock year after year.
Demand for GLP-1s and specialty care is rising fast—placing unprecedented pressure on traditional benefit models built for a different era.
High out-of-pocket costs lead 59% of employees to delay care—hurting health outcomes, satisfaction, and productivity.
A capped, employer-defined model that works alongside your existing plans—no medical-plan disruption.
Employers set a fixed annual specialty care budget and define eligible expenses.
Employees use funds for eligible specialty drugs and services—including GLP-1s, HRT, and weight management.
Programs work alongside existing health plans and Lifestyle Spending Accounts (LSAs).
Employer healthcare spend stays capped, predictable, and transparent.
A real-world example of how employees access the specialty care they need—while employers keep costs capped and predictable.
"Jessica, 41, uses her Specialty Care Account to access GLP-1 treatment through a telehealth provider, alongside coaching and wellbeing support. She receives reliable, ongoing care tailored to her needs—while her employer maintains predictable, employer-defined costs instead of absorbing high-cost claims through the medical plan."
What benefits and finance leaders ask when evaluating Specialty Care Accounts.
Specialty Care Accounts protect budgets from GLP-1 renewal shock while expanding access to the care employees are actively seeking. See how to shift from open-ended coverage to a predictable, capped model.